NCT06984523View on ClinicalTrials.gov

Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

May 12, 2028

Study Completion Date

May 12, 2028

Conditions
Leptomeningeal Metastasis
Interventions
RADIATION

Varian Eclipse

Varian TrueBeam linear accelerator with photon beam Volumetric Modulated Arc Therapy (VMAT) capability. Subjects will receive 3000 centigray (cGy) in 10 fractions at 300 cGy per fraction.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT06984523 - Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis | Biotech Hunter | Biotech Hunter